Eichhorn T
Laryngol Rhinol Otol (Stuttg). 1984 Jul;63(7):371-4.
The results of follow-up examinations on 52 patients suffering from acute unilateral vestibular paralysis are compared with the data of 295 patients with the same illness, compiled from 10 publications, and the successes of the treatment methods are compared. Function was restored, independent of the age of the patient, intensity of the symptoms at the onset of the illness and the extent of the functional damage. Concomitant diseases and so-called high-risk factors had no influence on the prognosis. The infusion-therapy carried out with rheologic or vasoactive drugs showed no better result than outpatient treatment. Neither could oral long-term treatment lasting longer than one year be established as being more efficient. The good prognostic expectations referring to an improvement of the symptoms could be explained by the combination of a peripheral recovery of the weak labyrinth and the process of central compensation. As long as the effectiveness of a risky infusion treatment has yet not been proven, and no reliable knowledge of the origin of this disease has been established, routine use of parenteral therapy must be considered with critical reservation.
对52例急性单侧前庭麻痹患者的随访检查结果与从10篇出版物中收集的295例同病患者的数据进行了比较，并对治疗方法的成效进行了比较。功能恢复情况与患者年龄、疾病发作时症状的严重程度以及功能损害的程度无关。伴发疾病和所谓的高危因素对预后没有影响。使用流变学或血管活性药物进行的输液治疗效果并不比门诊治疗更好。也无法确定超过一年的口服长期治疗更有效。症状改善方面良好的预后预期可以通过衰弱的迷路外周恢复与中枢代偿过程的结合来解释。只要有风险的输液治疗的有效性尚未得到证实，并且尚未确立对该疾病病因的可靠认识，就必须谨慎保留对肠外治疗的常规使用。
